Related references
Note: Only part of the references are listed.Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes
A. Garten et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages
Therese Hervee Mayi et al.
FEBS JOURNAL (2010)
The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids
Yi-Cheng Chang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans
Sheng Wen Liu et al.
CLINICAL ENDOCRINOLOGY (2009)
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
R. Aller et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells
Su-Ryun Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme
Javier R. Revollo et al.
CELL METABOLISM (2007)
Circulating visfatin level is correlated with inflammation, but not with insulin resistance
Kenji Oki et al.
CLINICAL ENDOCRINOLOGY (2007)
Visfatin:: A putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -: Resuks from the PIOSTAT study
A. Pfuetzner et al.
HORMONE AND METABOLIC RESEARCH (2007)
Serum concentration of visfatin in obese women
Barbara Zahorska-Markiewicz et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Pre-B-cell colony-enhancing factor (PBEF/visfatin) gene expression is modulated by NF-κB and AP-1 in human amniotic epithelial cells
C. E. Kendal et al.
PLACENTA (2007)
Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance
Teoman Dogru et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome
T. D. Filippatos et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians
Sreedharan Sandeep et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus
Kohzo Takebayashi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Human visfatin expression: Relationship to insulin sensitivity, intramyocellular lipids, and inflammation
Vijayalakshmi Varma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties
Alexander R. Moschen et al.
JOURNAL OF IMMUNOLOGY (2007)
Insulin-like effects of visfatin on human osteoblasts
H. Xie et al.
CALCIFIED TISSUE INTERNATIONAL (2007)
Visfatin concentration in Asian Indians is correlated with high density lipoprotein cholesterol and apolipoprotein A1
Jessica Smith et al.
CLINICAL ENDOCRINOLOGY (2006)
Free fatty acids normalize a rosiglitazone-induced visfatin release
Dominik G. Haider et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans
Claudio Pagano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The release of the adipocytokine visfatin is regulated by glucose and insulin
D. G. Haider et al.
DIABETOLOGIA (2006)
Macrophages in human visceral adipose tissue:: increased accumulation in obesity and a source of resistin and visfatin
CA Curat et al.
DIABETOLOGIA (2006)
Visfatin is an adipokine, but it is not regulated by thiazolidinediones
A Hammarstedt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
MP Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effect of PPAR-α and -γ agonist on the expression of visfatin, adiponectin, and TNF-α in visceral fat of OLETF rats
KC Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
J Berndt et al.
DIABETES (2005)
Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes
S Kralisch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Visfatin:: Gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats
N Klöting et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes
S Kralisch et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone
A Harte et al.
CIRCULATION (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes
AL Harte et al.
DIABETES OBESITY & METABOLISM (2003)
Resistin and type 2 diabetes: Regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes
PG McTernan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro
PG McTernan et al.
DIABETES (2002)
Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans
DB Savage et al.
DIABETES (2001)
Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes
S Ognjanovic et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2001)
Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue
PG McTernan et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Share Paper
